Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

25 May 2016 - 27 May 2016
06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016

New Metabolomics Kit Enables Use with Specialized Mass Spectrometer

By BiotechDaily International staff writers
Posted on 26 Mar 2013
Print article
Image: The new “AbsoluteIDQ p150” metabolomics kit (Photo courtesy of Biocrates).
Image: The new “AbsoluteIDQ p150” metabolomics kit (Photo courtesy of Biocrates).
A state-of-the-art metabolomics-based research kit has been specially designed for use with a triple stage quadrupole mass spectrometer, enabling additional laboratories to use such kits.

Biocrates Life Sciences AG (Innsbruck, Austria) introduced “AbsoluteIDQ p150,” the new edition of its well-established line of metabolomics-based research kits. The kit has been available for use with AB Sciex and Waters mass spectrometry systems, and has now been designed to also run on Thermo Scientific’s “TSQ Vantage” Triple Stage Quadrupole Mass Spectrometer, enabling more research labs to harness the power of targeted metabolite quantification with a ready-to-use kit system. Combined with a robust new ion source, second-generation ion optics, and hyperbolic quadrupoles, the “TSQ Vantage” mass spectrometer delivers both higher sensitivity and lower chemical noise.

AbsoluteIDQ p150 provides extensive metabolic information from a single targeted assay, quantifying 158 metabolites using a FIA-MS/MS method. It features the proprietary “MetIDQ” software, requires minute sample volumes (10 µL), and is suitable for use with a wide range of biological samples, making it an excellent choice with a cost-effective solution to measure endogenous metabolites under quality-controlled conditions in a researcher’s own laboratory. The Biocrates AbsoluteIDQ kits have been successfully applied in many different areas, including oncology, endocrinology, diabetes, nephrology, sepsis, and CNS disorders, in both clinical and pharmaceutical research. Biocrates mass spectrometry-based, standardized metabolomic kits provide multiplexing potential and superior accuracy and precision.

Related Links:
Biocrates




Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.